euro adhoc: Sartorius AG / Mergers - Acquisitions - Takeovers / AMF approves terms of the mandatory offer of Sartorius AG relating to the shares in Sartorius Stedim Biotech S.A.
--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------
11.07.2007
Today the French financial market authority Autorité des Marchés Financiers (AMF) has published its approval of the terms of the mandatory offer by Sartorius AG to the shareholders of Sartorius Stedim Biotech S.A. (former name: Stedim S.A.) to acquire their shares at the price of 43 Euro per share. The offer has been filed with the AMF on June 29, 2007. The offer will be open from July 13, 2007 until July 26, 2007. The execution and settlement of the offer marks a further essential step of the entire transaction combining the biotechnology division of Sartorius with the former Stedim S.A. in the course of which Sartorius AG has already acquired the majority of shares in the combined entity. Details regarding the terms of the offer may be derived from the offer document which is available on the website of Sartorius AG under www.sartorius.de.
end of announcement euro adhoc 11.07.2007 13:06:56
--------------------------------------------------------------------------------
ots Originaltext: Sartorius AG Im Internet recherchierbar: http://www.presseportal.de
Contact: Andreas Wiederhold Treasury & Investor Relations Telefon: +49 (0)551 308-1668 E-Mail: andreas.wiederhold@sartorius.com
Branche: Biotechnology ISIN: DE0007165607 WKN: 716560 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / official dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse München / free trade Börse Hannover / official dealing
